During the past decade, Universitäts-Augenklinik Bochum conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitäts-Augenklinik Bochum" #1 collaborator was "CRO Dr. med. Kottmann GmbH & Co. KG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitäts-Augenklinik Bochum" are "Presbyopia" (2 trials), "Cataract" (1 trials), "Glaucoma" (1 trials), "Open Angle Glaucoma" (1 trials) and "Primary Open Angle Glaucoma (POAG)" (1 trials). Many other conditions were trialed in "Universitäts-Augenklinik Bochum" in a lesser frequency.

Most popular intervention types in "Universitäts-Augenklinik Bochum" are "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "ARGOS-IO Sensor Pressure System" (1 trials), "ARGOS-IO system" (1 trials), "ARGOS-SC suprachoroidal pressure sensor" (1 trials), "AcuFocus Corneal Inlay" (1 trials) and "IC-8 IOL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitäts-Augenklinik Bochum" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Universitäts-Augenklinik Bochum". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Universitäts-Augenklinik Bochum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitäts-Augenklinik Bochum, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".